Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer
Abstract Ovarian cancer is a prevalent gynecologic malignancy with the second-highest mortality rate among gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for ovarian cancer; however, a majority of patients with ovarian cancer experience relapse and develop platinum...
Saved in:
| Main Authors: | Xin Cui, Juan Xu, Xuemei Jia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-024-05770-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alterations in mitochondrial base editors enhance targeted editing efficiency for mouse model generation
by: Seongho Hong, et al.
Published: (2025-09-01) -
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
by: Amel Karaa, et al.
Published: (2024-11-01) -
Extracellular mitochondria as promising diagnostic agents
by: О. I. Kit, et al.
Published: (2024-03-01) -
Mitochondrial DNA in atherosclerosis research progress: a mini review
by: Zheng Liu, et al.
Published: (2025-02-01) -
Development of a cell-penetrating peptide-based nanocomplex for long-term delivery of intact mitochondrial DNA into epithelial cells
by: Kyrie Wilson, et al.
Published: (2025-03-01)